Valproic acid ameliorates C. elegans dopaminergic neurodegeneration with implications for ERK-MAPK signaling. [electronic resource]
Producer: 20130903Description: 116-9 p. digitalISSN:- 1872-7972
- Animals
- Anticonvulsants -- pharmacology
- Caenorhabditis elegans
- Caenorhabditis elegans Proteins -- genetics
- Dopaminergic Neurons -- drug effects
- Humans
- MAP Kinase Kinase 2 -- genetics
- MAP Kinase Signaling System
- Mitogen-Activated Protein Kinase 1 -- genetics
- Nerve Degeneration -- metabolism
- Neuroprotective Agents -- pharmacology
- Parkinson Disease -- drug therapy
- RNA Interference
- Valproic Acid -- pharmacology
- alpha-Synuclein -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.